Sermorelin Research Products

Sermorelin research products consist of high-purity synthetic peptides representing the 29-amino-acid N-terminal sequence of human growth hormone-releasing hormone (GHRH). Engineered specifically for in vitro assays and preclinical laboratory investigations, these compounds allow researchers to evaluate pituitary receptor kinetics, somatotropine pathway signaling, and neuroendocrine regulation under strictly controlled experimental conditions.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Sermorelin research products consist of high-purity synthetic peptides representing the 29-amino-acid N-terminal sequence of human growth hormone-releasing hormone (GHRH). Engineered specifically for in vitro assays and preclinical laboratory investigations, these compounds allow researchers to evaluate pituitary receptor kinetics, somatotropine pathway signaling, and neuroendocrine regulation under strictly controlled experimental conditions.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Sermorelin](/research-peptides/sermorelin) (GRF 1-29 amide) is a synthetic analog of naturally occurring growth hormone-releasing hormone (GHRH).
  • The molecular architecture of [sermorelin](/research-peptides/sermorelin) is defined by its primary sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2.
  • At the cellular level, [sermorelin](/research-peptides/sermorelin) functions as a selective agonist of the growth hormone-releasing hormone receptor, a Class B G-protein-coupled receptor (GPCR) predominantly expressed on the cell membranes of anterior pituitary somatotrophs.
  • In vitro and preclinical rodent models have widely utilized [sermorelin](/research-peptides/sermorelin) research products to map neuroendocrine regulation, age-related somatopause mechanisms, and tissue regeneration dynamics.

Understanding Sermorelin Research Products in Laboratory Settings

Sermorelin (GRF 1-29 amide) is a synthetic analog of naturally occurring growth hormone-releasing hormone (GHRH). Comprising the functional 29-amino-acid truncated sequence of the native 44-amino-acid peptide, sermorelin retains full biological activity at the GHRH receptor level. In academic and industrial research environments, high-purity sermorelin research products serve as primary reference standards and experimental reagents for investigating endocrine feedback loops and pituitary somatotroph secretagogue pathways.

When purchasing compounds for preclinical protocols, investigators require high chemical fidelity and lot-to-lot consistency. PX1 Research synthesizes sermorelin research products utilizing solid-phase peptide synthesis (SPPS) techniques, followed by rigorous purification procedures. Designed strictly for in vitro testing and animal model exploration, these peptides provide researchers with stable, reproducible tools for evaluating receptor affinity, intracellular cAMP generation, and downstream gene expression.

Chemical Structure and Structural Biology of GRF (1-29)

The molecular architecture of sermorelin is defined by its primary sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. With a molecular formula of C149H246N44O42S and an exact monoisotopic mass of approximately 3357.88 Da, this peptide contains the minimal functional sequence required to bind and activate the human GHRH receptor (GHRHR).

The C-terminal amidation of sermorelin provides enzymatic stability against carboxypeptidases compared to unamidated fragments. In structural biology studies, the alpha-helical conformation of the N-terminal region (residues 1–15) is identified as the key binding domain responsible for activating transmembrane helices of the GHRH receptor. To view our full line of synthetic amino acid chains, browse our complete all peptides catalog.

Receptor Binding Kinematics and Intracellular Signaling Mechanisms

At the cellular level, sermorelin functions as a selective agonist of the growth hormone-releasing hormone receptor, a Class B G-protein-coupled receptor (GPCR) predominantly expressed on the cell membranes of anterior pituitary somatotrophs. Upon receptor engagement, sermorelin stimulates the Gas protein subunit, which subsequently activates membrane-bound adenylate cyclase.

This enzymatic activation converts intracellular adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP). Elevated cAMP levels recruit protein kinase A (PKA), driving the phosphorylation of cAMP response element-binding protein (CREB). In preclinical cell culture models, this cascade triggers transcription of growth hormone (GH) mRNA and facilitates calcium-dependent exocytosis of GH-containing secretory vesicles. Researchers interested in broader signaling research can explore additional references in our peptide research hub.

Preclinical Applications and Literature Overview

In vitro and preclinical rodent models have widely utilized sermorelin research products to map neuroendocrine regulation, age-related somatopause mechanisms, and tissue regeneration dynamics. Because sermorelin preserves the physiological feedback mechanism mediated by somatostatin (somatotropin release-inhibitory factor), preclinical studies demonstrate a preserved pulsatile release pattern of pituitary hormones rather than unchecked, tonic elevation.

Animal research models evaluating metabolic performance, lean muscle mass maintenance, nitrogen retention, and cellular repair frequently utilize sermorelin to observe endogenous pathway modulation. Investigations focusing on myocardial tissue repair, neuroprotection, and wound healing models often incorporate Sermorelin 5mg as a primary variable to isolate GHRH-mediated trophic responses from exogenous administration artifacts.

Comparative Analysis: Sermorelin vs. Other Secretagogue Research Peptides

In secretagogue research, investigators frequently evaluate sermorelin alongside other synthetic peptides targeting the GHRH receptor or ghrelin/growth hormone secretagogue receptor (GHSR-1a). Understanding the pharmacokinetic and structural differences among these research products is critical for proper assay design.

While sermorelin represents the native 1-29 sequence with a short biological half-life in rodent serum (~10–20 minutes), modified analogs such as CJC-1295 No DAC incorporate amino acid substitutions (such as D-Ala at position 2) to resist dipeptidyl peptidase-IV (DPP-IV) cleavage. Conversely, non-peptide and peptide ghrelin mimetics like Ipamorelin act on a completely distinct receptor (GHSR-1a). Comparative studies often utilize a dual-agonist approach, combining GHRH analogs with selective GHRPs to measure synergistic intracellular cAMP and calcium influx. For details on related secretagogues, review our article on ghrp-6 mechanisms.

Synthesis Quality and Purity Standards at PX1 Research

The fidelity of scientific data relies directly on the chemical purity of the research reagents used. PX1 Research enforces strict quality assurance protocols for every batch of sermorelin research products manufactured in our USA-based, GMP-compliant facilities.

Synthesized via modern automated solid-phase platforms, our sermorelin undergoes rigorous purification to eliminate truncated sequences, deletion peptides, unreacted reagents, and counter-ion impurities. Every lot is subjected to dual-stage analytical verification consisting of Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). Institutional buyers requiring scalable orders can learn more about account options on our wholesale accounts page.

Analytical Certificate of Analysis (COA) and Quality Metrics

Every item shipped from our California and Arizona logistics facilities is linked to a lot-specific Certificate of Analysis (COA) generated by an independent, ISO 17025-accredited laboratory. PX1 Research guarantees a minimum analytical purity threshold of 99% for all research peptides.

Key metrics published on our public COAs include:

1. RP-HPLC Chromatogram: Confirms chemical purity by demonstrating a single predominant peak, verifying the absence of degradation products or synthesis side-products.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass matching the theoretical value of 3357.88 Da.

3. Bacterial Endotoxin Testing: Executed via the Limulus Amebocyte Lysate (LAL) assay to ensure endotoxin levels remain below strictly established safe limits (<0.01 EU/mg), preventing confounding inflammatory cascades in sensitive cellular cultures.

Laboratory Handling, Reconstitution, and Storage Protocols

Sermorelin research products are supplied as sterile, lyophilized (freeze-dried) cakes or powders inside sealed glass vials to ensure long-term stability during transit and storage. To preserve tertiary structural integrity and prevent peptide hydrolysis or aggregation, laboratory personnel should follow standard handling procedures:

• Lyophilized Storage: Store at -20°C for long-term preservation (up to 24 months). Store at 2°C to 8°C for short-term storage (under 90 days). Protect from light exposure.

• Reconstitution Media: Reconstitute using sterile bacteriostatic water (containing 0.9% benzyl alcohol) or laboratory-grade sterile saline, depending on the requirements of the specific cell culture or assay protocol.

• Reconstitution Technique: Direct the solvent stream down the inner glass wall of the vial. Gently swirl or roll the vial until fully dissolved; never vortex or vigorously shake lyophilized peptides, as mechanical shear stress can cause protein denaturation.

• Aliquoting & Freezing: Once reconstituted, aliquot the solution into single-use microcentrifuge tubes to eliminate freeze-thaw cycles, which accelerate peptide degradation.

Why Laboratory Researchers Select PX1 Research

PX1 Research is an established USA supplier dedicated exclusively to serving university laboratories, biotechnology research organizations, and independent scientific facilities. We manufacture all compounds under stringent GMP-compliant standards, backed by ISO 17025 analytical testing.

With same-day shipping on orders placed Monday through Friday before cut-off times, fully traceable lot numbers, and transparent access to third-party testing documentation, PX1 Research provides the quality and reliability required for reproducible experimental results.

Frequently Asked Questions

What is the amino acid count and sequence of Sermorelin research products?

Sermorelin consists of a 29-amino-acid chain representing the active N-terminal fragment of endogenous GHRH (1-44). Its sequence is Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2.

What analytical methods verify the purity of PX1 Research Sermorelin?

PX1 Research verifies every lot using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to test chemical purity (>99%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular weight.

Are Sermorelin research products tested for endotoxins?

Yes. Every batch undergoes Limulus Amebocyte Lysate (LAL) endotoxin testing at an independent ISO 17025 accredited laboratory to guarantee low endotoxin levels suitable for in vitro cell culture and preclinical assays.

How should lyophilized Sermorelin be stored upon arrival at the lab?

Lyophilized sermorelin should be stored in a dry, dark environment at -20°C for long-term stability. Short-term storage at 2°C to 8°C is acceptable for up to three months.

Can Sermorelin research products be used for human consumption or therapeutic purposes?

No. All products sold by PX1 Research are strictly intended for laboratory research and in vitro or preclinical investigation. They are not intended for human or animal medical use, treatment, or administration.

How does Sermorelin compare to CJC-1295 in preclinical models?

Sermorelin matches the unmodified native GHRH 1-29 sequence with a shorter half-life (~10-20 minutes), whereas CJC-1295 includes amino acid substitutions designed to resist enzymatic degradation by DPP-IV, resulting in extended half-life characteristics in animal models.

Where are PX1 Research Sermorelin products manufactured and shipped from?

PX1 Research products are manufactured in USA-based, GMP-compliant facilities and shipped directly from our primary fulfillment warehouses located in California and Arizona.

How can researchers access the Certificate of Analysis (COA) for a specific lot?

Lot-specific Certificates of Analysis are publicly available on our website product pages or can be obtained by contacting support with the lot number printed on the product vial label.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.